World Pancreatic Cancer Day

There are several types of pancreatic cancer, depending on whether the cancer began in the exocrine or endocrine component. Pancreatic cancer is often difficult to diagnose due to the lack of symptoms until a later stage. However, as the cancer begins to grow, patients suffer from pain in the upper abdomen, loss of appetite and weight, yellowing of the skin and eyes, weakness and depression.

The risk of Pancreatic Cancer increases with age, and men are more prone to the disease than women. Other factors include family history of pancreatic cancer, smoking and unhealthy diet. In order to reduce the risk of pancreatic cancer, doctors advise exercising, maintaining a healthy weight, consuming less red meat and more fruits and vegetables.

Numerous clinical studies in Pancreatic Cancer are currently being conducted. They aim to improve the treatment safety and efficacy as well as the number of options available to the patients.

GCT has been supporting oncology clinical trials since 2001. We are excited to see the progress that’s been made in cancer treatment, and we hope to see more promising trial results in the near future.


Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.


GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login



© 2001—2021 Global Clinical Trials, LLC

All rights reserved.